Posted in | News | Nanoelectronics

Nanorobotics Company Tauriga Sciences to Present at World Resource Ventures 2013 Conference

Tauriga Sciences Inc. ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nanorobotics space, has today announced that the Company will be presenting at the World Resource Ventures 2013 Investor Conference ("the conference") on Wednesday, December 11, 2013 in Berlin, Germany.

The conference is being held at the Konrad-Adenauer-Foundation, located at Tiergartenstrasse 35, Berlin, Germany. The Company's invitation to present at this conference was a direct result of its successful and well received presentation at WaterVent 2013 in Ras Al Khaimah, U.A.E., this past week. While in the U.A.E., the company met with several Dubai based institutional investors and continues to progress in conversations with potential industry partners.

Attending this Berlin conference will be numerous European based institutional investors, venture capital funds, private individual investors ("angel investors"), investment banking firms, analysts, potential industry partners, and European media outlets.

Presenting on behalf of Tauriga Sciences Inc. will be its Chief Executive Officer ("CEO"), Mr. Seth M. Shaw.

On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly-owned subsidiary of Tauriga.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (OTCQB:TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at (www.tauriga.com).

About Pilus Energy LLC

A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, (www.pilusenergy.com).

About World Resource Ventures

Running matching forums since 1997, we leverage an excellent network within the European venture capital and corporate venture sector to help our presenting companies realize unexpected opportunities. Ulf Leonhard created and launched WorldResourceVentures as Europe's first investor-entrepreneur matchmaking forum having recognized the potential and unmet market need for targeted funding facilitation in the resource management sector. For more information, please visit the corporate website at: (www.worldresourceventures.com).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.